Companies: 10,795·Total market cap: $144.5T
AccuStem Sciences Limited

AccuStem Sciences Limited

ACMSYOTCHealthcare
$0.13
$-0.01(-7.14%)
Market Cap$0
P/E Ratio—
52W High$0.13
52W Low$0.12
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

AccuStem Sciences Limited (ACMSY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001850767 · ACMSY · OTC · as of Jun 9, 2026

Filing snapshot

75
Total Filings
10-Q
Latest Form
2026-05-15
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001850767 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-14
Fiscal Year End
Apr 14, 2026
Accession No.
0001493152-26-016559
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001850767 · Accession 0001493152-26-016559

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8-K
2025-11-26Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-15
View
10-KAnnual Report
10-K
2026-04-14
View
NT 10-KNT 10-K
NT 10-K
2026-03-31
View
8-KCurrent Report
8-K
2025-11-26
View
10-QQuarterly Report
10-Q
2025-11-12
View
10-QQuarterly Report
10-Q
2025-08-14
View
10-QQuarterly Report
10-Q
2025-05-20
View
NT 10-QNT 10-Q
NT 10-Q
2025-05-15
View
10-KAnnual Report
Annual Report
2025-04-03
View
NT 10-KNT 10-K
NT 10-K
2025-03-31
View
SEC STAFF ACTIONSEC STAFF ACTION
SEC STAFF ACTION
2025-02-21
View
8-K/ACurrent Report (Amended)
Current Report (Amended)
2025-01-02
View
8-KCurrent Report
Current Report
2024-12-30
View
10-QQuarterly Report
Quarterly Report
2024-11-18
View
NT 10-QNT 10-Q
NT 10-Q
2024-11-14
View
Showing 1–15 of 64 filingsForm 4 / 144 hidden· 75 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001850767  |  Exchange: OTC · Healthcare

AccuStem Sciences Limited (OTC: ACMSY) has submitted 75 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001850767, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is AccuStem Sciences Limited's most comprehensive regulatory disclosure. The most recent AccuStem Sciences Limited 10-K was filed on 2026-04-14 for fiscal year ending 2026. Historical ACMSY 10-K annual reports are available from 2021 through 2026.

Investors researching AccuStem Sciences Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
→ ACMSY Financials→ ACMSY Earnings→ ACMSY Insider Trades

Frequently Asked Questions

ACMSY SEC Filings · 8 questions

AccuStem Sciences Limited (ACMSY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 75 filings and access original documents at no cost. AccuStem Sciences Limited's CIK is 0001850767.

ACMSY SEC filingsAccuStem Sciences Limited SEC documentsfind ACMSY 10-K